IL6 and precursor B-cell acute lymphoblastic leukemia: The results from our experiments identify IL-6 as a key cytokine whose expression and secretion by mouse leukemic B-cells is induced when Pax5 is lost during the course of B-ALL development, and whose inhibition therapeutically targets leukemic cells.